BioSpace News Archive

Biotech Beach

HemaCare Announces OneBlood Exercises Second Investment Tranche Option

Under the terms of the agreement signed January 6, 2017, OneBlood is purchasing an additional 363,786 shares at $3.44 per share.

January 8, 2018
·
2 min read
Business

Innovus Pharma Enters Into License and Distribution Agreement with Acerus Pharmaceuticals for the Commercialization of UriVarx in Canada

Under the agreement, Innovus Pharma will receive an up-front license payment and is eligible to receive up to CAD$1.65 million dollars in sales milestone payments plus minimum order quantities at an agreed-upon transfer price.

January 8, 2018
·
7 min read
Business

NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year

Total revenue for the full year of 2017 is expected to be approximately $18 million, up 51% from 2017.

January 8, 2018
·
4 min read
Policy

FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection

Merck today announced that the FDA has accepted for review two New Drug Applications (NDAs) for doravirine, the company’s investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infection in adults.

January 8, 2018
·
7 min read
Drug Development

Merck’s Keytruda Significantly Improved Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy in Patients With Stage 3 Resected High-Risk Melanoma

The safety profile of Keytruda in this trial was consistent with that observed in previously reported studies involving patients with advanced melanoma.

January 8, 2018
·
26 min read
Policy

Ascentage Pharma Announces Acceptance of IND Application by China FDA for Clinical Study of Novel IAP Inhibitor to Treat Hepatitis B Infection

APG-1387 is the first IAP inhibitor to be studied in patients with HBV in China.

January 8, 2018
·
4 min read
Genetown

Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company

Sage Therapeutics today announced that in a corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco.

January 8, 2018
·
9 min read
Critical Outcome Technologies Changes Name to Cotinga Pharmaceuticals

The effective date of the name change, approved by shareholders in December 2017, is expected to be January 10, 2018.

January 8, 2018
·
4 min read
Business

Invitae More Than Doubles Annual Volume, Exceeds Full-Year 2017 Guidance, and Projects Momentum to Continue in 2018

For 2018, the company announced it anticipates accessioning at least 250,000 samples and generating at least $120M in revenue for the combined organization.

January 8, 2018
·
4 min read
Pharm Country

IDEXX Launches SDMA in the Point of Care With IDEXX Catalyst SDMA Test

IDEXX Labs today announced that the IDEXX Catalyst SDMA Test will be commercially available to all North American customers on January 16, 2018.

January 8, 2018
·
6 min read